ORM2 levels are associated with MASLD, while studies suggest its potential as a therapeutic target for liver diseases, particularly those related to lipid metabolism and steatohepatitis36. This evidence concerns the gene ORM2 and metabolic dysfunction-associated steatotic liver disease.